[Vaccination against hepatitis B and the risk of multiple sclerosis].
A paper on sclerosis multiplex as sequellae of vaccination against hepatitis B with recombinant vaccine was published in the journal of "Neurology" in September 2004. Problem was evaluated in United Kingdom on the ground of General Practice Research Database (GPRD). In 1996 similar problem was evaluated with negative results in several studies. Just now in opinions of many institutions as well as many persons vaccination against hepatitis B with recombinant vaccine should be continued in similar way as it was performed to this time.
Magdzik
Wiesław
W
Państwowy Zakład Higieny Zakład Epidemiologii, Warszawa.
Zieliński
Andrzej
A
D007722:Health Knowledge, Attitudes, Practice; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000592:standards*; D006801:Humans; D007114:Immunization / Q000592:standards; D007391:International Cooperation; D009103:Multiple Sclerosis / Q000139:chemically induced / Q000209:etiology*; D011044:Poland; D018570:Risk Assessment; D006113:United Kingdom; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000592:standards
D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic